AURA

Aura Biosciences, Inc.

Contracts

Total Value

Stock Metrics

6.8%

Short % Float

18.5d to cover · Moderate squeeze

54.0%

Inst % Float

10 holders · 2026-06-30

Matrix Capital Man

Top Holder

6.7% of float

93.4M sh

Public Float

46/100

Dilution Score

Medium

11 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

46/100

MEDIUM

Inst: 53.96% · Top: Matrix Capital Management Company LP

Biotech Analytics

Ocular Oncology

30.09

Squeeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications100

Dilution Risk46

Clinical Trials42

Short Interest30